These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4594836)

  • 41. [Comparative study of the preventive properties of sera obtained by immunization with Shigella flexneri strains of varying degrees of virulence].
    Miroliubova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Sep; 0(9):136-7. PubMed ID: 1106084
    [No Abstract]   [Full Text] [Related]  

  • 42. Reuse of Salmonella and Shigella absorbing cells for preparing monospecific Salmonella O and Shigella antisera.
    Gray SB; Green JH; Harrell WK; Britt L; Bolin RC
    Appl Microbiol; 1974 Aug; 28(2):320-2. PubMed ID: 4605063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Production of antibodies against Shigella flexneri antigen types I and II by means of affinity chromatography].
    Seltmann G; Horn G
    Z Allg Mikrobiol; 1978; 18(6):457-8. PubMed ID: 82304
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study of genetic control of synthesis of type III and 6th group-specific antigens of Flexner shigellae].
    Bondarenko VM; Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):79-86. PubMed ID: 68643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the significance of type-specific antigen for the virulence of Shigella flexneri 2a in studying recombinants of definite genetic classes].
    Petrovskaia VG; Blinova NI
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):69-74. PubMed ID: 4941815
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparison of rabbit and mouse antisera to Shigella paradysenteriae.
    DOAK BW; HALBERT SP
    J Immunol; 1946 Feb; 52():113-20. PubMed ID: 21018814
    [No Abstract]   [Full Text] [Related]  

  • 47. [Recombination variability of Shigella flexneri bacilli].
    Lachowicz TM; Lagowska-Zlotorzycka M; Kolodyński J
    Postepy Hig Med Dosw; 1972; 26(5):657-74. PubMed ID: 4569134
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies of the pathogenetic role of humoral antibodies reacting with subcellular organ antigens. II. Passive immunization of rats with anti-rat rabbit immune sera.
    Dóbiás G; Balázs M
    Immunology; 1967 Apr; 12(4):389-94. PubMed ID: 6023758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the transfer of lymph node cells. VII. Transfer of cells incubated in vitro with filtrates of trypsin-treated suspensions of Shigella paradysenteriae.
    FARBER MB; HARRIS S; HARRIS TN; OGBURN CA
    J Exp Med; 1956 Nov; 104(5):645-61. PubMed ID: 13367335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of a model of salmonella infection for testing immunity to typhoid fever by means of a bacteremia test and in passive immunity experiments].
    L'vovskaia NV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):31-4. PubMed ID: 6004739
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on immunity to staphylococcal infection in mice. IV. The role of specific and nonspecific immunity.
    Ekstedt RD
    J Infect Dis; 1966 Oct; 116(4):514-22. PubMed ID: 5928625
    [No Abstract]   [Full Text] [Related]  

  • 52. Specific and nonspecific passive immunity in infant rabbit cholera.
    Gillmore JD; Versage PM; Phillips RA
    J Infect Dis; 1966 Jun; 116(3):313-8. PubMed ID: 5940330
    [No Abstract]   [Full Text] [Related]  

  • 53. INTERFERENCE WITH ESTABLISHMENT OF IMMUNOLOGIC TOLERANCE TO SHIGELLA ANTIGENS IN NEONATAL MICE BY SPECIFIC ANTISERUM.
    FRIEDMAN H
    J Immunol; 1965 Jun; 94():921-6. PubMed ID: 14321435
    [No Abstract]   [Full Text] [Related]  

  • 54. [Biochemical composition of preparations from Sh. flexneri 550 original cultures and their mutants with increased radiation resistance].
    Sinilova NG; Pershina ZG; Duplishcheva AP; Ivanov KK
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Aug; 48(8):102-7. PubMed ID: 5099089
    [No Abstract]   [Full Text] [Related]  

  • 55. Experimental infection of mice with Mycoplasma agalactiae.
    Smith GR
    J Comp Pathol; 1967 Apr; 77(2):199-202. PubMed ID: 6034498
    [No Abstract]   [Full Text] [Related]  

  • 56. [Protective role of type-specific Shigella flexneri 2A antigen in interaction with immune sera in passive protection experiments on a "lung" model].
    Blinova NI
    Vestn Akad Med Nauk SSSR; 1973; 28(11):44-7. PubMed ID: 4594836
    [No Abstract]   [Full Text] [Related]  

  • 57. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a.
    Pore D; Chowdhury P; Mahata N; Pal A; Yamasaki S; Mahalanabis D; Chakrabarti MK
    Vaccine; 2009 Sep; 27(42):5855-64. PubMed ID: 19660587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
    Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
    Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.